M17.0 M54.5 M53.2 M53.8 M53.9 M54.6 M54.8 M54.9 M99.02 M99.03 M99.04 M99.82 M99.83 M99.84 M99.92 M99.93 M99.94 M42.0 M42.1 M42.9 M16.0 M99.85 M99.86 M99.95 M99.96 M25.55 M25.85 M25.95 M99.86 M99.96 M25.56 M25.86
Conditions
Interventions
Group 1: Retrospective recording of treatment using the Vivira app. It is an intra-individual control: i.e. the study is single-arm, the control is the preliminary (= historical) findings of the same
Sponsors
Vivira Health Lab GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients which are • patients with chronic pain of the musculoskeletal system • and baseline pain score of 1 or more as from Jan. 09, 2018 and later
Exclusion criteria
Exclusion criteria: • Patients who were not able to follow the exercise protocol. • Patients with severe vision problems • No pain, pain score=0 • Discontinuation with no pain value following week 2: these patients were considered as trial users but not as ITT-users. • Non-premium users: these patients are also considered as test users and not as ITT-users. These were test users trying Vivira only for a few days for free. • prescription of analgetics • acute malignant disease • Dementia • drug or alcohol abuse • Previous use of a movement therapy DiGA (Vivira, Kaia, etc.) • limited legal capacity • significantly impaired vision or blindness • serious internal disorders (condition after heart attack, severe organ failure, need for dialysis, etc.) • serious neurological disorders (stroke, paralysis, multiple sclerosis, convulsions, etc.) • rheumatic disease • Osteoporosis • Pregnancy • Bleeding tendency / haemophilia • Gait insecurity and frequent falls • acute herniated disc or other disorder with radiation to the legs (radiculopathy, sensorimotor failure) • Herniated disc in the past • Spinal column infection in the past or acute • Spine OP • Spinal tumor • Injury of the spinal column • Joint replacement (TEP) or partial joint replacement • Osteotomy (an operation to correct the axis of the leg) • joint infection in the past or acute • free joint body • Osteochondrosis dissecans or bone necrosis • Injury to the knee or hip joint • Hip Dysplasia • Arthrodesis (joint stiffening) in one of the two knee or hip joints • Acute instability of the knee or hip joint • Knee or hip surgery in the last year • clinically relevant bone marrow edema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain VNRS (validated numerical-verbal rating scale) after 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Proprietary functional test | — |
Countries
Germany
Contacts
Public ContactPhilip Heimann
Vivira Health Lab GmbH
Outcome results
None listed